This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Eugene N. Myers, MD
University of Pittsburgh (Pa) School of Medicine

William F. Donaldson, MD
Children's Hospital of Pittsburgh

JAMA. 1990;264(24):3144.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

We are writing with respect to the report entitled "Biomedical Information, Peer Review, and Conflict of Interest as They Influence Public Health,"¹ which appeared in your March 9 issue. The authors of that report (a bioengineer, an economist, and a lawyer) present their version of "an actual case" in which they (and we) have been involved. Central to virtually every point Dr Cantekin and his coauthors attempt to make is their portrayal of Dr Cantekin's 1986 submission to the New England Journal of Medicine as a "dissenting manuscript" concerning the Otitis Media Research Center's Antibiotic for Otitis Media With Effusion—I (AB-OME-I) clinical trial. That portrayal is misleading and erroneous.

The manuscript submitted by Dr Cantekin et al to the New England Journal of Medicine (Cantekin et al) was not written as a dissent to the Otitis Media Research Center's report of results of the AB-OME-I trial, . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?